The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Pathological verification of ischemic score in differentiation of dementias
Abstract
Fourteen case histories of persons who had a histological diagnosis of either senile dementia of the Alzheimer type, multiinfarct dementia, or a mixed dementia composed of these two types and who showed evidence of a moderate to severe dementia on psychological testing were rated for the presence of thirteen clinical features comprising Hachinski's Ischemic Score. These features are frequently considered primarily characteristic of vascular dementia. Persons with senile dementia of the Alzheimer type were clearly differentiable from persons with multiinfarct dementia and mixed dementia, while the latter two groups were indistinguishable from one another. In our sample, eight features were found to characterize those persons with vascular dementia. These data verify the usefulness of the Ischemic Score in differentiating between senile dementia of the Alzheimer type and vascular dementia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric statistics for the behavioral sciences
McGinn, L. C. (1957) · Journal of the Franklin Institute · doi:10.1016/0016-0032(57)90766-4 · Cited by 7,204
Blessed, G., Tomlinson, B. E., & Roth, M. (1968) · British Journal of Psychiatry · doi:10.1192/bjp.114.512.797 · Cited by 4,117
. Cerebral blood flow in dementia.
Hachinski, V. C., Iliff, L. D., Zilhka, E., Du Boulay, G. H., McAllister, V. L., Marshall, J., Russell, R. W. R., & Symon, L. (1975) · Archives of Neurology · doi:10.1001/archneur.1975.00490510088009 · Cited by 3,186
Observations on the brains of demented old people
Tomlinson, B. E., Blessed, G., & Roth, M. (1970) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(70)90063-8 · Cited by 2,084
MULTI-INFARCT DEMENTIA A CAUSE OF MENTAL DETERIORATION IN THE ELDERLY
HACHINSKI, V (1974) · The Lancet · doi:10.1016/s0140-6736(74)91496-2 · Cited by 1,093
Alzheimer's Disease: Senile Dementia and Related Disorders
Bellur, S. N. (1979) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1979.03300200059031 · Cited by 803
MacLennan, R., & Jensen, O. M. (1977) · PubMed · Cited by 685
NEUROPATHOLOGIC CHANGES IN ARTERIOSCLEROTIC PSYCHOSES AND THEIR PSYCHIATRIC SIGNIFICANCE
ROTHSCHILD, D. (1942) · Archives of Neurology And Psychiatry · doi:10.1001/archneurpsyc.1942.02290090073005 · Cited by 67
Farmer, P., Peck, A., & Terry, R. D. (1976) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-197605000-00142 · Cited by 56
Self-citationMental Illness and The Ageing Brain
Linell, E. A. (1963) · American Journal of Psychiatry · doi:10.1176/ajp.120.1.101-a · Cited by 41
Cited by
Mild Cognitive Impairment: Clinical Characterization and Outcome
Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999) · Archives of Neurology · doi:10.1001/archneur.56.3.303 · Cited by 8,980
A New Clinical Scale for the Staging of Dementia
Hughes, C. P., Berg, L., Danziger, W., Coben, L. A., & Martin, R. L. (1982) · British Journal of Psychiatry · doi:10.1192/bjp.140.6.566 · Cited by 7,056
A new rating scale for Alzheimer's disease
(1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.11.1356 · Cited by 4,175
Self-citationCornell scale for depression in dementia
Alexopoulos, G. S., Abrams, R. C., Young, R. C., & Shamoian, C. A. (1988) · Biological Psychiatry · doi:10.1016/0006-3223(88)90038-8 · Cited by 2,678
Memantine in Moderate-to-Severe Alzheimer's Disease
Reisberg, B., Doody, R., Stöffler, A., Schmitt, F., Ferris, S., & Möbius, H. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa013128 · Cited by 2,043
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
Salloway, S., Sperling, R., Fox, N. C., Blennow, K., Klunk, W., Raskind, M., Sabbagh, M., Honig, L. S., Porsteinsson, A. P., Ferris, S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1304839 · Cited by 1,960
Doody, R. S., Stevens, J. C., Beck, C., Dubinsky, R. M., Kaye, J. A., Gwyther, L., Mohs, R. C., Thal, L. J., Whitehouse, P. J., DeKosky, S. T., et al. (2001) · Neurology · doi:10.1212/wnl.56.9.1154 · Cited by 1,720
Knopman, D. S., DeKosky, S. T., Cummings, J. L., Chui, H., Corey–Bloom, J., Relkin, N., Small, G. W., Miller, B., & Stevens, J. C. (2001) · Neurology · doi:10.1212/wnl.56.9.1143 · Cited by 1,410
Tariot, P. N., Farlow, M. R., Grossberg, G. T., Graham, S. M., McDonald, S., Gergel, I., & for the Memantine Study Group (2004) · JAMA · doi:10.1001/jama.291.3.317 · Cited by 1,403
The Clinical Diagnosis of Alzheimer's Disease
Wade, J. P. H., Mirsen, T. R., Hachinski, V. C., Fisman, M., Lau, C., & Merskey, H. (1987) · Archives of Neurology · doi:10.1001/archneur.1987.00520130016010 · Cited by 1,374
Morris, J. C., Weintraub, S., Chui, H. C., Cummings, J., DeCarli, C., Ferris, S., Foster, N. L., Galasko, D., Graff-Radford, N., Peskind, E. R., et al. (2006) · Alzheimer Disease & Associated Disorders · doi:10.1097/01.wad.0000213865.09806.92 · Cited by 950
Grundman, M. (2004) · Archives of Neurology · doi:10.1001/archneur.61.1.59 · Cited by 972
Crook, T., Bartus, R. T., Ferris, S. H., Whitehouse, P., Cohen, G. D., & Gershon, S. (1986) · Developmental Neuropsychology · doi:10.1080/87565648609540348 · Cited by 938
Quantitative gait dysfunction and risk of cognitive decline and dementia
Verghese, J., Wang, C., Lipton, R. B., Holtzer, R., & Xue, X. (2007) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.106914 · Cited by 796
Roberts, R. O., Geda, Y. E., Knopman, D. S., Cha, R. H., Pankratz, V. S., Boeve, B. F., Ivnik, R. J., Tangalos, E. G., Petersen, R. C., & Rocca, W. A. (2008) · Neuroepidemiology · doi:10.1159/000115751 · Cited by 793
Petersen, R. C. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03520400044042 · Cited by 780
Bondi, M. W., Initiative, F. T. A. D. N., Edmonds, E. C., Jak, A. J., Clark, L. R., Delano-Wood, L., McDonald, C. R., Nation, D. A., Libon, D. J., Au, R., et al. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-140276 · Cited by 772
A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease
Salloway, S., Sperling, R., Gilman, S., Fox, N. C., Blennow, K., Raskind, M., Sabbagh, M., Honig, L. S., Doody, R., van Dyck, C. H., et al. (2009) · Neurology · doi:10.1212/wnl.0b013e3181c67808 · Cited by 753
A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease
Turner, R. S., Thomas, R. G., Craft, S., van Dyck, C. H., Mintzer, J., Reynolds, B. A., Brewer, J. B., Rissman, R. A., Raman, R., Aisen, P. S., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000002035 · Cited by 736
Rinne, J. O., Brooks, D. J., Rossor, M. N., Fox, N. C., Bullock, R., Klunk, W. E., Mathis, C. A., Blennow, K., Barakos, J., Okello, A. A., et al. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70043-0 · Cited by 701
Abnormality of Gait as a Predictor of Non-Alzheimer's Dementia
Verghese, J., Lipton, R. B., Hall, C. B., Kuslansky, G., Katz, M. J., & Buschke, H. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020441 · Cited by 690
Jessen, F. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.30 · Cited by 674
The prevalence and causes of dementia in people under the age of 65 years
Harvey, R. J. (2003) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.74.9.1206 · Cited by 649
A Double-Blind, Placebo-Controlled Multicenter Study of Tacrine for Alzheimer's Disease
Davis, K. L., Thal, L. J., Gamzu, E. R., Davis, C. S., Woolson, R. F., Gracon, S. I., Drachman, D. A., Schneider, L. S., Whitehouse, P. J., Hoover, T. M., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199210293271801 · Cited by 626
Verbal fluency in aging and dementia
Rosen, W. G. (1980) · Journal of Clinical Neuropsychology · doi:10.1080/01688638008403788 · Cited by 595
Self-citationGinkgo biloba for cognitive impairment and dementia
Birks, J., & Grimley Evans, J. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003120.pub3 · Cited by 581
Outcome over seven years of healthy adults with and without subjective cognitive impairment
Reisberg, B., Shulman, M. B., Torossian, C., Leng, L., & Zhu, W. (2010) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2009.10.002 · Cited by 568
A phase III randomized trial of gantenerumab in prodromal Alzheimer’s disease
for the SCarlet RoAD Investigators, Ostrowitzki, S., Lasser, R. A., Dorflinger, E., Scheltens, P., Barkhof, F., Nikolcheva, T., Ashford, E., Retout, S., Hofmann, C., et al. (2017) · Alzheimer's Research & Therapy · doi:10.1186/s13195-017-0318-y · Cited by 567
“Clinical status was documented by an MMSE score ≥ 24, a CDR global score of 0.5 with an accompanying memory box score of 0.5 or 1.0, abnormal memory function based on an FCSRT score of either < 17 free recall, < 40 total recall, or < 20 free recall, and < 42 total recall; a score ≤ 4 on the modified Hachinski Ischemic…”
MethodInfluentialChinese Mini Mental Status in Elderly Chinese: A Population-Based Normative Study
Li, H., Jia, J., & Yang, Z. (2016) · Journal of Alzheimer’s Disease · doi:10.3233/jad-160119 · Cited by 561
Estrogen for Alzheimer’s disease in women: Randomized, double-blind, placebo-controlled trial
Henderson, V. W., Paganini-Hill, A., Miller, B. L., Elble, R. J., Reyes, P. F., Shoupe, D., McCleary, C. A., Klein, R. A., Hake, A. M., & Farlow, M. R. (2000) · Neurology · doi:10.1212/wnl.54.2.295 · Cited by 550
Baseline MRI predictors of conversion from MCI to probable AD in the ADNI cohort
Risacher, S., Saykin, A., Wes, J., Shen, L., Firpi, H., & McDonald, B. (2009) · Current Alzheimer Research · doi:10.2174/156720509788929273 · Cited by 538
Banerjee, S., Hellier, J., Dewey, M., Romeo, R., Ballard, C., Baldwin, R., Bentham, P., Fox, C., Holmes, C., Katona, C., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60830-1 · Cited by 532
Decreased EEG synchronization in Alzheimer’s disease and mild cognitive impairment
Koenig, T., Prichep, L., Dierks, T., Hubl, D., Wahlund, L. O., John, E. R., & Jelic, V. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.03.008 · Cited by 517
Hippocampal damage and memory impairments as possible early brain complications of type 2 diabetes
Gold, S. M., Dziobek, I., Sweat, V., Tirsi, A., Rogers, K., Bruehl, H., Tsui, W., Richardson, S., Javier, E., & Convit, A. (2007) · Diabetologia · doi:10.1007/s00125-007-0602-7 · Cited by 489
Age-specific incidence rates of Alzheimer’s disease: The Baltimore Longitudinal Study of Aging
Kawas, C., Gray, S., Brookmeyer, R., Fozard, J., & Zonderman, A. (2000) · Neurology · doi:10.1212/wnl.54.11.2072 · Cited by 472
Doody, R. S., Gavrilova, S. I., Sano, M., Thomas, R. G., Aisen, P. S., Bachurin, S. O., Seely, L., & Hung, D. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61074-0 · Cited by 460
Development of dementing illnesses in an 80‐year‐old volunteer cohort
Katzman, R., Aronson, M., Fuld, P., Kawas, C., Brown, T., Morgenstern, H., Frishman, W., Gidez, L., Eder, H., & Ooi, W. L. (1989) · Annals of Neurology · doi:10.1002/ana.410250402 · Cited by 452
Self-citationRandomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe
Feldman, H. H., Doody, R. S., Kivipelto, M., Sparks, D. L., Waters, D. D., Jones, R. W., Schwam, E., Schindler, R., Hey-Hadavi, J., DeMicco, D. A., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181d6476a · Cited by 438
Marshall, G. A., Rentz, D. M., Frey, M. T., Locascio, J. J., Johnson, K. A., Sperling, R. A., & Initiative, A. D. N. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2010.04.005 · Cited by 437
Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab
Ostrowitzki, S. (2012) · Archives of Neurology · doi:10.1001/archneurol.2011.1538 · Cited by 431
Skrobot, O. A., Black, S. E., Chen, C., DeCarli, C., Erkinjuntti, T., Ford, G. A., Kalaria, R. N., O'Brien, J., Pantoni, L., Pasquier, F., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2017.09.007 · Cited by 431
Frequency of hippocampal formation atrophy in normal aging and Alzheimer's disease
De Leon, M. J., George, A. E., Golomb, J., Tarshish, C., Convit, A., Kluger, A., De Santi, S., Mc Rae, T., Ferris, S. H., Reisberg, B., et al. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(96)00213-8 · Cited by 429
Dementia after stroke: Baseline frequency, risks, and clinical features in a hospitalized cohort
Tatemichi, T. K., Desmond, D. W., Mayeux, R., Paik, M., Stern, Y., Sano, M., Remien, R. H., Williams, J. B. W., Mohr, J. P., Hauser, W. A., et al. (1992) · Neurology · doi:10.1212/wnl.42.6.1185 · Cited by 420
The Aging, Demographics, and Memory Study: Study Design and Methods
Langa, K. M., Plassman, B. L., Wallace, R. B., Herzog, A. R., Heeringa, S. G., Ofstedal, M. B., Burke, J. R., Fisher, G. G., Fultz, N. H., Hurd, M. D., et al. (2005) · Neuroepidemiology · doi:10.1159/000087448 · Cited by 413
A Randomized, Double-Blind, Study of Rofecoxib in Patients with Mild Cognitive Impairment
on behalf of the Rofecoxib Protocol 078 study group, Thal, L. J., Ferris, S. H., Kirby, L., Block, G. A., Lines, C. R., Yuen, E., Assaid, C., Nessly, M. L., Norman, B. A., et al. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300690 · Cited by 402
Mutual information analysis of the EEG in patients with Alzheimer's disease
Jeong, J., Gore, J. C., & Peterson, B. S. (2001) · Clinical Neurophysiology · doi:10.1016/s1388-2457(01)00513-2 · Cited by 397
Mixed Dementia: Emerging Concepts and Therapeutic Implications
Langa, K. M., Foster, N. L., & Larson, E. B. (2004) · JAMA · doi:10.1001/jama.292.23.2901 · Cited by 398
APOE -ε4 count predicts age when prevalence of AD increases, then declines: The Cache County Study
Breitner, J. C. S., Wyse, B. W., Anthony, J. C., Welsh-Bohmer, K. A., Steffens, D. C., Norton, M. C., Tschanz, J. T., Plassman, B. L., Meyer, M. R., Skoog, I., et al. (1999) · Neurology · doi:10.1212/wnl.53.2.321 · Cited by 397
The Fluorodeoxyglucose 18F Scan in Alzheimer's Disease and Multi-infarct Dementia
Benson, D. F., Kuhl, D. E., Hawkins, R. A., Phelps, M. E., Cummings, J. L., & Tsai, S. Y. (1983) · Archives of Neurology · doi:10.1001/archneur.1983.04050110029003 · Cited by 392
A double-blind, placebo-controlled trial of diclofenac/misoprostol in Alzheimer’s disease
Scharf, S., Mander, A., Ugoni, A., Vajda, F., & Christophidis, N. (1999) · Neurology · doi:10.1212/wnl.53.1.197 · Cited by 390
Individual analysis of EEG frequency and band power in mild Alzheimer's disease
Moretti, D. V., Babiloni, C., Binetti, G., Cassetta, E., Dal Forno, G., Ferreric, F., Ferri, R., Lanuzza, B., Miniussi, C., Nobili, F., et al. (2004) · Clinical Neurophysiology · doi:10.1016/s1388-2457(03)00345-6 · Cited by 387
Wilcock, G., M??bius, H. J., & St??ffler, A. (2002) · International Clinical Psychopharmacology · doi:10.1097/00004850-200211000-00005 · Cited by 381
Jung, C.-R., Lin, Y.-T., & Hwang, B.-F. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-140855 · Cited by 380
Hock, C., Villringer, K., Müller-Spahn, F., Wenzel, R., Heekeren, H., Schuh-Hofer, S., Hofmann, M., Minoshima, S., Schwaiger, M., Dirnagl, U., et al. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00122-4 · Cited by 377
Cortical abnormalities in Alzheimer's disease
Foster, N. L., Chase, T. N., Mansi, L., Brooks, R., Fedio, P., Patronas, N. J., & Di Chiro, G. (1984) · Annals of Neurology · doi:10.1002/ana.410160605 · Cited by 372
Quantitative NMR measurements of hippocampal atrophy in Alzheimer's disease
Seab, J. P., Jagust, W. J., Wong, S. T. S., Roos, M. S., Reed, B. R., & Budinger, T. F. (1988) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910080210 · Cited by 364
Clinically diagnosed Alzheimer's disease: Autopsy results in 150 cases
Joachim, C. L., Morris, J. H., & Selkoe, D. J. (1988) · Annals of Neurology · doi:10.1002/ana.410240110 · Cited by 360
Clock Completion: An Objective Screening Test for Dementia
Watson, Y. I., Arfken, C. L., & Birge, S. J. (1993) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1993.tb07308.x · Cited by 339
Talking while walking: The effect of a dual task in aging and Alzheimer's disease
Camicioli, R., Howieson, D., Lehman, S., & Kaye, J. (1997) · Neurology · doi:10.1212/wnl.48.4.955 · Cited by 332
Incidence of AD may decline in the early 90s for men, later for women: The Cache County study
Miech, R. A., Breitner, J. C. S., Zandi, P. P., Khachaturian, A. S., Anthony, J. C., & Mayer, L. (2002) · Neurology · doi:10.1212/wnl.58.2.209 · Cited by 331
Atorvastatin for the Treatment of Mild to Moderate Alzheimer Disease: Preliminary Results
Sparks, D. L., Sabbagh, M. N., Connor, D. J., Lopez, J., Launer, L. J., Browne, P., Wasser, D., Johnson-Traver, S., Lochhead, J., & Ziolwolski, C. (2005) · Archives of Neurology · doi:10.1001/archneur.62.5.753 · Cited by 319
Sparing of semantic memory in Alzheimer's disease.
Nebes, R. D., Martin, D. C., & Horn, L. C. (1984) · Journal of Abnormal Psychology · doi:10.1037//0021-843x.93.3.321 · Cited by 315
Sources of cortical rhythms in adults during physiological aging: A multicentric EEG study
Babiloni, C., Binetti, G., Cassarino, A., Dal Forno, G., Del Percio, C., Ferreri, F., Ferri, R., Frisoni, G., Galderisi, S., Hirata, K., et al. (2006) · Human Brain Mapping · doi:10.1002/hbm.20175 · Cited by 314
Knopman, D. S., Gottesman, R. F., Sharrett, A. R., Wruck, L. M., Windham, B. G., Coker, L., Schneider, A. L. C., Hengrui, S., Alonso, A., Coresh, J., et al. (2016) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1016/j.dadm.2015.12.002 · Cited by 313
Stricker, N. H., Schweinsburg, B. C., Delano-Wood, L., Wierenga, C. E., Bangen, K. J., Haaland, K. Y., Frank, L. R., Salmon, D. P., & Bondi, M. W. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2008.11.027 · Cited by 307
Memantine Treatment in Mild to Moderate Alzheimer Disease: A 24-Week Randomized, Controlled Trial
Peskind, E. R., Potkin, S. G., Pomara, N., Ott, B. R., Graham, S. M., Olin, J. T., & McDonald, S. (2006) · The American Journal of Geriatric Psychiatry · doi:10.1097/01.jgp.0000224350.82719.83 · Cited by 307
Neuropathologic Substrates of Ischemic Vascular Dementia
Vinters, H. V., Ellis, W. G., Zarow, C., Zaias, B. W., Jagust, W. J., Mack, W. J., & Chui, H. C. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.11.931 · Cited by 304
Patterns of Motor Impairment in Normal Aging, Mild Cognitive Decline, and Early Alzheimer' Disease
Kluger, A., Gianutsos, J. G., Golomb, J., Ferris, S. H., George, A. E., Franssen, E., & Reisberg, B. (1997) · The Journals of Gerontology Series B: Psychological Sciences and Social Sciences · doi:10.1093/geronb/52b.1.p28 · Cited by 303
Efficacy of donepezil in mild cognitive impairment: A randomized placebo-controlled trial
Salloway, S., Ferris, S., Kluger, A., Goldman, R., Griesing, T., Kumar, D., & Richardson, S. (2004) · Neurology · doi:10.1212/01.wnl.0000134664.80320.92 · Cited by 300
Anastasiou, C. A., Yannakoulia, M., Kosmidis, M. H., Dardiotis, E., Hadjigeorgiou, G. M., Sakka, P., Arampatzi, X., Bougea, A., Labropoulos, I., & Scarmeas, N. (2017) · PLOS ONE · doi:10.1371/journal.pone.0182048 · Cited by 299
Laakso, M. P., Soininen, H., Partanen, K., Helkala, E. L., Hartikainen, P., Vainio, P., Hallikainen, M., Hänninen, T., & Riekkinen Sr, P. J. (1995) · Journal of Neural Transmission - Parkinson's Disease and Dementia Section · doi:10.1007/bf02252964 · Cited by 292
Alzheimer Disease: Evaluation of a Functional MR Imaging Index as a Marker
Li, S.-J., Li, Z., Wu, G., Zhang, M.-J., Franczak, M., & Antuono, P. G. (2002) · Radiology · doi:10.1148/radiol.2251011301 · Cited by 292
Towards defining the neuropathological substrates of vascular dementia
Kalaria, R. N., Kenny, R. A., Ballard, C. G., Perry, R., Ince, P., & Polvikoski, T. (2004) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2004.09.019 · Cited by 291
Babiloni, C., Binetti, G., Cassetta, E., Cerboneschi, D., Dal Forno, G., Del Percio, C., Ferreri, F., Ferri, R., Lanuzza, B., Miniussi, C., et al. (2004) · NeuroImage · doi:10.1016/j.neuroimage.2003.09.028 · Cited by 288
Metrifonate benefits cognitive, behavioral, and global function in patients with Alzheimer's disease
Morris, J. C., Cyrus, P. A., Orazem, J., Mas, J., Bieber, F., Ruzicka, B. B., & Gulanski, B. (1998) · Neurology · doi:10.1212/wnl.50.5.1222 · Cited by 287
Babiloni, C., Binetti, G., Cassetta, E., Forno, G. D., Percio, C. D., Ferreri, F., Ferri, R., Frisoni, G., Hirata, K., Lanuzza, B., et al. (2006) · Clinical Neurophysiology · doi:10.1016/j.clinph.2005.09.019 · Cited by 285
Organic Delusions: Phenomenology, Anatomical Correlations, and Review
Cummings, J. L. (1985) · British Journal of Psychiatry · doi:10.1192/bjp.146.2.184 · Cited by 284
Slowing of EEG in Parkinson's disease
Soikkeli, R., Partanen, J., Soininen, H., Pääkkönen, A., & Riekkinen, P. (1991) · Electroencephalography and Clinical Neurophysiology · doi:10.1016/0013-4694(91)90134-p · Cited by 283
Intrusions as a sign of Alzheimer dementia chemical and pathological verification
Fuld, P. A., Katzman, R., Davies, P., & Terry, R. D. (1982) · Annals of Neurology · doi:10.1002/ana.410110208 · Cited by 281
Self-citationPrichep, L. S., John, E. R., Ferris, S. H., Rausch, L., Fang, Z., Cancro, R., Torossian, C., & Reisberg, B. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.07.021 · Cited by 278
Zaudig, M., Mittelhammer, J., Hiller, W., Pauls, A., Thora, C., Morinigo, A., & Mombour, W. (1991) · Psychological Medicine · doi:10.1017/s0033291700014811 · Cited by 278
Spanish Multicenter Normative Studies (NEURONORMA Project): Methods and Sample Characteristics
Pena-Casanova, J., Blesa, R., Aguilar, M., Gramunt-Fombuena, N., Gomez-Anson, B., Oliva, R., Molinuevo, J. L., Robles, A., Barquero, M. S., Antunez, C., et al. (2009) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acp027 · Cited by 271
Wetterling, T., Kanitz, R.-D., & Borgis, K.-J. (1996) · Stroke · doi:10.1161/01.str.27.1.30 · Cited by 266
Laakso, M. P., Soininen, H., Partanen, K., Lehtovirta, M., Hallikainen, M., Hänninen, T., Helkala, E.-L., Vainio, P., & Riekkinen, P. J. (1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00006-2 · Cited by 267
Clinical Correlates of Vascular Parkinsonism
Winikates, J., & Jankovic, J. (1999) · Archives of Neurology · doi:10.1001/archneur.56.1.98 · Cited by 266
Alafuzoff, I., Iqbal, K., Friden, H., Adolfsson, R., & Winblad, B. (1987) · Acta Neuropathologica · doi:10.1007/bf00688184 · Cited by 266
Volumes of the Entorhinal and Perirhinal Cortices in Alzheimer’s Disease
Juottonen, K., Laakso, M. P., Insausti, R., Lehtovirta, M., Pitkänen, A., Partanen, K., & Soininen, H. (1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00007-4 · Cited by 262
A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer disease
Salloway, S., Sperling, R., Keren, R., Porsteinsson, A. P., van Dyck, C. H., Tariot, P. N., Gilman, S., Arnold, D., Abushakra, S., Hernandez, C., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e3182309fa5 · Cited by 258
Efficacy of Donepezil in Early-Stage Alzheimer Disease: A Randomized Placebo-Controlled Trial
Seltzer, B. (2004) · Archives of Neurology · doi:10.1001/archneur.61.12.1852 · Cited by 257
Mapping local hippocampal changes in Alzheimer's disease and normal ageing with MRI at 3 Tesla
Frisoni, G. B., Ganzola, R., Canu, E., Rub, U., Pizzini, F. B., Alessandrini, F., Zoccatelli, G., Beltramello, A., Caltagirone, C., & Thompson, P. M. (2008) · Brain · doi:10.1093/brain/awn280 · Cited by 256
Preventable senility: a call for action against the vascular dementias
HACHINSKI, P. (1992) · The Lancet · doi:10.1016/0140-6736(92)92177-h · Cited by 234
Zetterberg, H. (2012) · Archives of Neurology · doi:10.1001/archneurol.2012.90 · Cited by 234
Geda, Y. E., Knopman, D. S., Mrazek, D. A., Jicha, G. A., Smith, G. E., Negash, S., Boeve, B. F., Ivnik, R. J., Petersen, R. C., Pankratz, V. S., et al. (2006) · Archives of Neurology · doi:10.1001/archneur.63.3.435 · Cited by 230
A phase1 study of stereotactic gene delivery of AAV2-NGF for Alzheimer’s disease
Rafii, M. S., Baumann, T. L., Bakay, R. A. E., Ostrove, J. M., Siffert, J., Fleisher, A. S., Herzog, C. D., Barba, D., Pay, M., Salmon, D. P., et al. (2014) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2013.09.004 · Cited by 223
Provenzano, F. A., Muraskin, J., Tosto, G., Narkhede, A., Wasserman, B. T., Griffith, E. Y., Guzman, V. A., Meier, I. B., Zimmerman, M. E., Brickman, A. M., et al. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.1321 · Cited by 192
Alzheimer’s disease can be accurately diagnosed in very mildly impaired individuals
Salmon, D. P., Thomas, R. G., Pay, M. M., Booth, A., Hofstetter, C. R., Thal, L. J., & Katzman, R. (2002) · Neurology · doi:10.1212/wnl.59.7.1022 · Cited by 189
Self-citationVecchio, F., Miraglia, F., Marra, C., Quaranta, D., Vita, M. G., Bramanti, P., & Rossini, P. M. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-132087 · Cited by 182
BABILONI, C., FRISONI, G., PIEVANI, M., VECCHIO, F., LIZIO, R., BUTTIGLIONE, M., GEROLDI, C., FRACASSI, C., EUSEBI, F., & FERRI, R. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2008.08.005 · Cited by 171
Camargos, E. F., Louzada, L. L., Quintas, J. L., Naves, J. O. S., Louzada, F. M., & Nóbrega, O. T. (2014) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2013.12.174 · Cited by 170
Metadata
- Authors
- Rosen, W. G., Terry, R. D., Fuld, P. A., Katzman, R., & Peck, A.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 1980-05
- Volume
- 7
- Issue
- 5
- Pages
- 486-488
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2119062449
- Cited by
- 1,273
- References
- 10
- FWCI
- 10.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.